Cargando…

Testing for COVID-19

Accurate diagnostic tests that provide results in a timely manner are essential for the clinical and public health management of COVID-19 disease The choice as to which test to use will depend on the clinical presentation and the stage of the illness Nucleic acid tests, using real-time reverse trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Brischetto, Anna, Robson, Jenny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738692/
https://www.ncbi.nlm.nih.gov/pubmed/33363303
http://dx.doi.org/10.18773/austprescr.2020.067
_version_ 1783623174054739968
author Brischetto, Anna
Robson, Jenny
author_facet Brischetto, Anna
Robson, Jenny
author_sort Brischetto, Anna
collection PubMed
description Accurate diagnostic tests that provide results in a timely manner are essential for the clinical and public health management of COVID-19 disease The choice as to which test to use will depend on the clinical presentation and the stage of the illness Nucleic acid tests, using real-time reverse transcriptase-polymerase chain reaction, are the most appropriate for diagnosing acute infection. Combined deep nasal (or nasopharyngeal) and throat swabs are the preferred sample Serology can be used to diagnose previous infection, more than 14 days after the onset of symptoms Antigen tests are in development and their role is not yet defined Interpretation of results must take into account the pre-test probability of the patient having the disease. This is based on their clinical presentation and epidemiological risk
format Online
Article
Text
id pubmed-7738692
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-77386922020-12-23 Testing for COVID-19 Brischetto, Anna Robson, Jenny Aust Prescr Diagnostic Tests Accurate diagnostic tests that provide results in a timely manner are essential for the clinical and public health management of COVID-19 disease The choice as to which test to use will depend on the clinical presentation and the stage of the illness Nucleic acid tests, using real-time reverse transcriptase-polymerase chain reaction, are the most appropriate for diagnosing acute infection. Combined deep nasal (or nasopharyngeal) and throat swabs are the preferred sample Serology can be used to diagnose previous infection, more than 14 days after the onset of symptoms Antigen tests are in development and their role is not yet defined Interpretation of results must take into account the pre-test probability of the patient having the disease. This is based on their clinical presentation and epidemiological risk NPS MedicineWise 2020-10-15 2020-12 /pmc/articles/PMC7738692/ /pubmed/33363303 http://dx.doi.org/10.18773/austprescr.2020.067 Text en (c) NPS MedicineWise http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle Diagnostic Tests
Brischetto, Anna
Robson, Jenny
Testing for COVID-19
title Testing for COVID-19
title_full Testing for COVID-19
title_fullStr Testing for COVID-19
title_full_unstemmed Testing for COVID-19
title_short Testing for COVID-19
title_sort testing for covid-19
topic Diagnostic Tests
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738692/
https://www.ncbi.nlm.nih.gov/pubmed/33363303
http://dx.doi.org/10.18773/austprescr.2020.067
work_keys_str_mv AT brischettoanna testingforcovid19
AT robsonjenny testingforcovid19